Belbuca and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Belbuca (buprenorphine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Vitamin D3, and have Pain.

The phase IV clinical study analyzes which people have Itching when taking Belbuca. It is created by eHealthMe based on reports of 2,994 people who have side effects when taking Belbuca from the FDA, and is updated regularly.

What is Belbuca?

Belbuca has active ingredients of buprenorphine hydrochloride. eHealthMe is studying from 3,022 Belbuca users. Check the latest studies of Belbuca.

What is Itching?

Itching is found to be associated with 3,210 drugs and 4,535 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 16, 2026

2,994 people reported to have side effects when taking Belbuca.
Among them, 42 people (1.4%) have Itching.

Among these 42 people:

How long have people been on Belbuca when they have Itching? *

What is the gender of people who have Itching when taking Belbuca? *

female: 60.53 %
male: 39.47 %

What is the age of people who have Itching when taking Belbuca? *

What are other drugs people take besides Belbuca? *

What are other side effects people have besides Itching? *

Headache (pain in head): 17 people, 40.48%
Fatigue (feeling of tiredness): 17 people, 40.48%
Nausea (feeling of having an urge to vomit): 16 people, 38.10%
Rashes (redness): 16 people, 38.10%
Pain: 15 people, 35.71%
Dizziness: 15 people, 35.71%
Joint Pain: 15 people, 35.71%
Pain In Extremity: 14 people, 33.33%
Weakness: 12 people, 28.57%
Oedema (fluid collection in tissue): 12 people, 28.57%

What are the existing conditions these people have? *

Pain: 12 people, 28.57%
Immunodeficiency Common Variable: 11 people, 26.19%
Dehydration (dryness resulting from the removal of water): 6 people, 14.29%
Lichen Myxoedematosus (deposition of acid mucopolysaccharides in the skin): 6 people, 14.29%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 4.76%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 2 people, 4.76%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.76%
Stress And Anxiety: 1 person, 2.38%
High Blood Pressure: 1 person, 2.38%
Back Disorder: 1 person, 2.38%

* Approximation only. Some reports may have incomplete information.

Do you take Belbuca and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Belbuca:

Belbuca (3,022 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Belbuca:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,210 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,535 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride (the active ingredients of Belbuca) and Belbuca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.